Gene Therapy Latest News | Experimental Gene Therapy Studies

Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment

09 October 2020

Gene Therapy for Hemophilia: Anticipating the Unexpected

11 August 2020

ISTH and EAHAD Announce Partnership on Educational Components of the ISTH Gene Therapy in Hemophilia Education Initiative

01 October 2020

Request for Proposals: Artificial Intelligence/Machine Learning Research in Hemophilia

06 August 2020

Gene Therapy BAY 2599023 Showing Steady FVIII Activity, Safety in Trial
24 July 2020
Spark Therapeutics Announces Updated Data on SPK-8011 from Phase 1/2 Clinical Trial in Hemophilia A at ISTH 2020 Virtual Congress
12 July 2020
Freeline Raises $120M for Pivotal Trial of FLT180a, a Gene Therapy Candidate for Hemophilia B
10 July 2020
Investigational Gene Therapy Results in Huge Drop in Bleeding Rates and Factor VIII Usage, Updated Data Show
24 June 2020

I agree with the Terms and conditions and the Privacy policy

About

Supported by educational grants from BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc

Essential SSL